Determination of SU5416, a novel angiogenesis inhibitor, in human plasma by liquid chromatography

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 805, Issue 1, 2004, Pages 135-140

  Tohnya, Tanyifor M ^a   Kim, Sonia ^a   Fine, Howard A ^a   Dunn, Lara ^a   Figg, William D ^a   Sparreboom, Alex ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis inhibitor; SU5416

Indexed keywords

ACETONITRILE; BODY FLUIDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHARMACOKINETICS; PRECIPITATION (CHEMICAL); PROTEINS; SEPARATION;

FLOW RATES; HUMAN PLASMA; ULTRAVIOLET DETECTION;

BIOMEDICAL ENGINEERING;

ACETIC ACID; ACETONITRILE; AMMONIUM ACETATE; ANGIOGENESIS INHIBITOR; CHRYSIN; SEMAXANIB; SOLVENT;

ACCURACY; AQUEOUS SOLUTION; ARTICLE; CALIBRATION; CANCER PATIENT; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG INFUSION; FEMALE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MALIGNANT NEOPLASTIC DISEASE; MATERIALS; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; ULTRAVIOLET RADIATION;

ANGIOGENESIS INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; INDOLES; PYRROLES; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 2042507729     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2004.02.036     Document Type: Article

References (13)

1. Rosen L.S. Cancer Control. 9:2002;36
2. Kasahara Y., Tuder R.M., Taraseviciene-Stewart L., Le Cras T.D., Abman S., Hirth P.K., Waltenberger J., Voelkel N.F. J. Clin. Invest. 106:2000;1311
3. Krystal G.W., Honsawek S., Kiewlich D., Liang C., Vasile S., Sun L., McMahon G., Lipson K.E. Cancer Res. 61:2001;3660
4. Itokawa T., Nokihara H., Nishioka Y., Sone S., Iwamoto Y., Yamada Y., Cherrington J., McMahon G., Shibuya M., Kuwano M., Ono M. Mol. Cancer Ther. 1:2002;295
5. Mendel D.B., Laird A.D., Smolich B.D., Blake R.A., Liang C., Hannah A.L., Shaheen R.M., Ellis L.M., Weitman S., Shawver L.K., Cherrington J.M. Anticancer Drug Des. 15:2000;29
6. Kuenen B.C., Levi M., Meijers J.C., Kakkar A.K., van Hinsbergh V.W., Kostense P.J., Pinedo H.M., Hoekman K. Arterioscler. Thromb. Vasc. Biol. 22:2002;1500
7. Mesters R.M., Padro T., Bieker R., Steins M., Kreuter M., Goner M., Kelsey S., Scigalla P., Fiedler W., Buchner T., Berdel W.E. Blood. 98:2001;241
8. Giles F.J., Stopeck A.T., Silverman L.R., Lancet J.E., Cooper M.A., Hannah A.L., Cherrington J.M., O'Farrell A.M., Yuen H.A., Louie S.G., Hong W., Cortes J.E., Verstovsek S., Albitar M., O'Brien S.M., Kantarjian H.M., Karp J.E. Blood. 102:2003;795
9. Fiedler W., Staib P., Kuse R., Duhrsen U., Flasshove M., Cavalli F., Hossfeld D.K., Berdel W.E. Cancer J. 7(Suppl. 3):2001;S129
10. Stopeck A., Sheldon M., Vahedian M., Cropp G., Gosalia R., Hannah A. Clin. Cancer Res. 8:2002;2798
11. Kuenen B.C., Rosen L., Smit E.F., Parson M.R., Levi M., Ruijter R., Huisman H., Kedde M.A., Noordhuis P., van der Vijgh W.J., Peters G.J., Cropp G.F., Scigalla P., Hoekman K., Pinedo H.M., Giaccone G. J. Clin. Oncol. 20:2002;1657
12. Mendel D.B., Schreck R.E., West D.C., Li G., Strawn L.M., Tanciongco S.S., Vasile S., Shawver L.K., Cherrington J.M. Clin. Cancer Res. 6:2000;4848
13. Antonian L., Zhang H., Yang C., Wagner G., Shawver L.K., Shet M., Ogilvie B., Madan A., Parkinson A. Drug Metab. Dispos. 28:2000;1505